SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1cm8'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DRE_A_MTXA161_1 (DIHYDROFOLATE REDUCTASE)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	5 / 12	ALA A 305 MET A 291 LEU A 141 ILE A 215 LEU A 159	None	1.12A	1dreA-1cm8A: undetectable	1dreA-1cm8A: 18.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GTI_A_CCSA47_0 (GLUTATHIONE S-TRANSFERASE)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	4 / 7	THR A 114 LEU A 116 GLY A 157 LEU A 170	None None ANP A 400 (-4.3A) ANP A 400 (-4.0A)	0.93A	1gtiA-1cm8A: undetectable	1gtiA-1cm8A: 22.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GTI_E_CCSE47_0 (GLUTATHIONE S-TRANSFERASE)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	4 / 7	THR A 114 LEU A 116 GLY A 157 LEU A 170	None None ANP A 400 (-4.3A) ANP A 400 (-4.0A)	1.00A	1gtiE-1cm8A: 0.0	1gtiE-1cm8A: 22.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RX3_A_MTXA161_1 (DIHYDROFOLATE REDUCTASE)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	5 / 12	ALA A 305 MET A 291 LEU A 141 ILE A 215 LEU A 159	None	1.12A	1rx3A-1cm8A: undetectable	1rx3A-1cm8A: 18.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XKK_A_FMMA91_2 (EPIDERMAL GROWTH FACTOR RECEPTOR)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	5 / 9	VAL A 41 LYS A 56 LEU A 89 LEU A 107 MET A 112	ANP A 400 (-4.1A) ANP A 400 (-2.9A) None None None	0.68A	1xkkA-1cm8A: 21.2	1xkkA-1cm8A: 27.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PGZ_D_COCD401_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	4 / 6	TYR A 106 TRP A 21 TYR A 12 GLN A 31	None	1.36A	2pgzD-1cm8A: 0.0 2pgzE-1cm8A: undetectable	2pgzD-1cm8A: 21.04 2pgzE-1cm8A: 21.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QEI_A_CXXA802_1 (TRANSPORTER)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	4 / 6	SER A 229 ARG A 189 ARG A 192 ILE A 197	None PTR A 185 ( 3.6A) PTR A 185 ( 3.1A) None	1.15A	2qeiA-1cm8A: 0.0	2qeiA-1cm8A: 21.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2TSR_B_D16B409_1 (THYMIDYLATE SYNTHASE)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	4 / 8	ARG A 176 ILE A 149 LEU A 141 GLY A 140	TPO A 183 ( 3.9A) None None None	0.78A	2tsrB-1cm8A: undetectable	2tsrB-1cm8A: 22.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GCS_A_BAXA401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	5 / 12	ALA A 54 LEU A 78 ILE A 87 ILE A 144 HIS A 151	ANP A 400 (-3.3A) None ANP A 400 (-4.9A) None None	0.98A	3gcsA-1cm8A: 24.5	3gcsA-1cm8A: 60.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GCS_A_BAXA401_2 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	4 / 6	MET A 81 VAL A 86 ILE A 149 ILE A 169	None	0.74A	3gcsA-1cm8A: 23.5	3gcsA-1cm8A: 60.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GP0_A_NILA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 11)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	7 / 12	ALA A 54 LEU A 78 ILE A 87 HIS A 151 ALA A 160 LEU A 170 ASP A 171	ANP A 400 (-3.3A) None ANP A 400 (-4.9A) None ANP A 400 ( 4.7A) ANP A 400 (-4.0A) MG A 402 (-2.3A)	1.04A	3gp0A-1cm8A: 37.8	3gp0A-1cm8A: 63.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GP0_A_NILA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 11)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	9 / 12	VAL A 41 ALA A 54 GLU A 74 LEU A 77 LEU A 78 ILE A 87 HIS A 151 ALA A 160 LEU A 170	ANP A 400 (-4.1A) ANP A 400 (-3.3A) None None None ANP A 400 (-4.9A) None ANP A 400 ( 4.7A) ANP A 400 (-4.0A)	0.76A	3gp0A-1cm8A: 37.8	3gp0A-1cm8A: 63.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GP0_A_NILA1_2 (MITOGEN-ACTIVATED PROTEIN KINASE 11)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	5 / 7	ARG A 70 VAL A 86 LEU A 107 MET A 112 ILE A 169	None	0.75A	3gp0A-1cm8A: 37.8	3gp0A-1cm8A: 63.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEC_A_STIA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	5 / 12	ALA A 54 GLU A 74 LEU A 78 ILE A 87 LEU A 170	ANP A 400 (-3.3A) None None ANP A 400 (-4.9A) ANP A 400 (-4.0A)	0.77A	3hecA-1cm8A: 36.7	3hecA-1cm8A: 61.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEC_A_STIA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	6 / 12	VAL A 33 ALA A 54 LYS A 56 GLU A 74 LEU A 78 ILE A 87	ANP A 400 ( 4.9A) ANP A 400 (-3.3A) ANP A 400 (-2.9A) None None ANP A 400 (-4.9A)	0.68A	3hecA-1cm8A: 36.7	3hecA-1cm8A: 61.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEC_A_STIA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	5 / 12	VAL A 33 ALA A 54 LYS A 56 LEU A 77 LEU A 78	ANP A 400 ( 4.9A) ANP A 400 (-3.3A) ANP A 400 (-2.9A) None None	0.73A	3hecA-1cm8A: 36.7	3hecA-1cm8A: 61.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEG_A_BAXA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	6 / 12	VAL A 33 VAL A 41 ALA A 54 LYS A 56 GLU A 74 ILE A 144	ANP A 400 ( 4.9A) ANP A 400 (-4.1A) ANP A 400 (-3.3A) ANP A 400 (-2.9A) None None	1.09A	3hegA-1cm8A: 36.9	3hegA-1cm8A: 61.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEG_A_BAXA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	7 / 12	VAL A 33 VAL A 41 ALA A 54 LYS A 56 LEU A 78 ILE A 87 ILE A 144	ANP A 400 ( 4.9A) ANP A 400 (-4.1A) ANP A 400 (-3.3A) ANP A 400 (-2.9A) None ANP A 400 (-4.9A) None	1.14A	3hegA-1cm8A: 36.9	3hegA-1cm8A: 61.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEG_A_BAXA1_2 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	5 / 6	MET A 81 VAL A 86 ILE A 149 HIS A 151 ILE A 169	None	0.60A	3hegA-1cm8A: 36.9	3hegA-1cm8A: 61.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEG_A_BAXA1_2 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	5 / 6	VAL A 86 ILE A 149 HIS A 151 ILE A 169 LEU A 170	None None None None ANP A 400 (-4.0A)	0.77A	3hegA-1cm8A: 36.9	3hegA-1cm8A: 61.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LFA_A_1N1A361_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	6 / 8	VAL A 33 ALA A 54 LYS A 56 GLU A 74 LEU A 107 MET A 112	ANP A 400 ( 4.9A) ANP A 400 (-3.3A) ANP A 400 (-2.9A) None None None	0.50A	3lfaA-1cm8A: 35.6	3lfaA-1cm8A: 61.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3N23_A_OBNA1_1 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	5 / 11	PRO A 353 ASP A 91 VAL A 53 ALA A 44 ILE A 55	None	1.39A	3n23A-1cm8A: 0.0	3n23A-1cm8A: 16.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OHT_A_1N1A1000_1 (P38A)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	6 / 12	VAL A 33 VAL A 41 ALA A 54 LEU A 78 ILE A 87 LEU A 170	ANP A 400 ( 4.9A) ANP A 400 (-4.1A) ANP A 400 (-3.3A) None ANP A 400 (-4.9A) ANP A 400 (-4.0A)	0.57A	3ohtA-1cm8A: 8.3	3ohtA-1cm8A: 58.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OHT_A_1N1A1000_1 (P38A)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	6 / 12	VAL A 33 VAL A 41 ALA A 54 LYS A 56 LEU A 78 ILE A 87	ANP A 400 ( 4.9A) ANP A 400 (-4.1A) ANP A 400 (-3.3A) ANP A 400 (-2.9A) None ANP A 400 (-4.9A)	0.60A	3ohtA-1cm8A: 8.3	3ohtA-1cm8A: 58.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OHT_B_1N1B1000_1 (P38A)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	6 / 12	VAL A 41 ALA A 54 LEU A 78 ILE A 87 GLY A 113 LEU A 170	ANP A 400 (-4.1A) ANP A 400 (-3.3A) None ANP A 400 (-4.9A) None ANP A 400 (-4.0A)	0.80A	3ohtB-1cm8A: 6.2	3ohtB-1cm8A: 58.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OHT_B_1N1B1000_1 (P38A)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	6 / 12	VAL A 41 ALA A 54 LYS A 56 LEU A 78 ILE A 87 GLY A 113	ANP A 400 (-4.1A) ANP A 400 (-3.3A) ANP A 400 (-2.9A) None ANP A 400 (-4.9A) None	0.66A	3ohtB-1cm8A: 6.2	3ohtB-1cm8A: 58.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3QL0_A_FOLA160_0 (DIHYDROFOLATE REDUCTASE)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	5 / 12	ALA A 305 MET A 291 LEU A 141 ILE A 215 LEU A 159	None	1.20A	3ql0A-1cm8A: undetectable	3ql0A-1cm8A: 17.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SEL_X_DXCX75_0 (CYTOCHROME C7)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	4 / 8	ILE A 169 LEU A 159 MET A 216 GLY A 213	None	0.87A	3selX-1cm8A: undetectable	3selX-1cm8A: 12.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UCJ_A_AZMA229_2 (CARBONIC ANHYDRASE)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	3 / 3	GLN A 63 PHE A 67 TYR A 59	None	0.95A	3ucjB-1cm8A: undetectable	3ucjB-1cm8A: 19.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UCJ_B_AZMB229_1 (CARBONIC ANHYDRASE)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	3 / 3	GLN A 63 PHE A 67 TYR A 59	None	0.96A	3ucjA-1cm8A: undetectable	3ucjA-1cm8A: 19.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WAR_A_NIOA401_1 (CASEIN KINASE II SUBUNIT ALPHA)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	4 / 8	VAL A 41 LYS A 56 ILE A 87 ASP A 171	ANP A 400 (-4.1A) ANP A 400 (-2.9A) ANP A 400 (-4.9A) MG A 402 (-2.3A)	0.59A	3warA-1cm8A: 29.8	3warA-1cm8A: 30.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZE_A_BAXA1201_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	7 / 12	VAL A 41 ALA A 54 LYS A 56 GLU A 74 LEU A 78 PHE A 111 HIS A 151	ANP A 400 (-4.1A) ANP A 400 (-3.3A) ANP A 400 (-2.9A) None None ANP A 400 ( 4.3A) None	0.58A	3wzeA-1cm8A: 20.8	3wzeA-1cm8A: 25.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ASD_A_BAXA1500_1 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	7 / 12	VAL A 41 ALA A 54 LYS A 56 GLU A 74 LEU A 78 PHE A 111 HIS A 151	ANP A 400 (-4.1A) ANP A 400 (-3.3A) ANP A 400 (-2.9A) None None ANP A 400 ( 4.3A) None	0.59A	4asdA-1cm8A: 20.6	4asdA-1cm8A: 24.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4GH8_A_MTXA201_1 (DIHYDROFOLATE REDUCTASE)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	5 / 12	ALA A 305 MET A 291 LEU A 141 ILE A 215 LEU A 159	None	1.13A	4gh8A-1cm8A: undetectable	4gh8A-1cm8A: 17.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4HAJ_A_DXCA75_0 (PPCA)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	4 / 7	ILE A 169 LEU A 159 MET A 216 GLY A 213	None	0.94A	4hajA-1cm8A: undetectable	4hajA-1cm8A: 17.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4I41_A_MIXA500_1 (SERINE/THREONINE-PRO TEIN KINASE PIM-1)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	8 / 12	VAL A 41 ALA A 54 ILE A 87 ASP A 115 ASP A 153 LYS A 155 ASN A 158 ASP A 171	ANP A 400 (-4.1A) ANP A 400 (-3.3A) ANP A 400 (-4.9A) ANP A 400 (-3.4A) ANP A 400 ( 4.7A) ANP A 400 (-3.5A) MG A 401 ( 2.9A) MG A 402 (-2.3A)	0.94A	4i41A-1cm8A: 24.7	4i41A-1cm8A: 27.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IIZ_B_LURB201_1 (TRANSTHYRETIN)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	4 / 8	GLU A 297 THR A 206 LEU A 294 VAL A 207	None	0.94A	4iizB-1cm8A: 0.5	4iizB-1cm8A: 15.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L9I_A_8PRA601_1 (RHODOPSIN KINASE)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	4 / 7	VAL A 41 ALA A 54 LEU A 58 MET A 109	ANP A 400 (-4.1A) ANP A 400 (-3.3A) None ANP A 400 (-4.6A)	0.62A	4l9iA-1cm8A: 10.4	4l9iA-1cm8A: 22.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4OGR_A_ADNA401_1 (CYCLIN-DEPENDENT KINASE 9)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	5 / 8	VAL A 41 ALA A 54 ASP A 115 ASN A 158 ASP A 171	ANP A 400 (-4.1A) ANP A 400 (-3.3A) ANP A 400 (-3.4A) MG A 401 ( 2.9A) MG A 402 (-2.3A)	0.61A	4ogrA-1cm8A: 25.9	4ogrA-1cm8A: 32.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4UXQ_A_0LIA1752_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	4 / 7	VAL A 41 ILE A 87 ARG A 152 ILE A 169	ANP A 400 (-4.1A) ANP A 400 (-4.9A) TPO A 183 ( 2.8A) None	0.75A	4uxqA-1cm8A: 19.2	4uxqA-1cm8A: 24.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XV2_A_P06A801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	5 / 12	VAL A 41 ALA A 54 LYS A 56 ASP A 171 PHE A 172	ANP A 400 (-4.1A) ANP A 400 (-3.3A) ANP A 400 (-2.9A) MG A 402 (-2.3A) None	0.70A	4xv2A-1cm8A: 21.4	4xv2A-1cm8A: 25.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XV2_B_P06B801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	5 / 12	ALA A 54 LYS A 56 LEU A 78 ASP A 171 PHE A 172	ANP A 400 (-3.3A) ANP A 400 (-2.9A) None MG A 402 (-2.3A) None	0.85A	4xv2B-1cm8A: 21.6	4xv2B-1cm8A: 25.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CSH_B_ACTB401_0 (CASEIN KINASE II SUBUNIT ALPHA)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	4 / 5	ARG A 73 ARG A 152 LEU A 174 VAL A 186	TPO A 183 ( 2.8A) TPO A 183 ( 2.8A) None PTR A 185 ( 2.8A)	0.95A	5cshB-1cm8A: 29.4	5cshB-1cm8A: 28.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CSW_A_P06A801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	6 / 12	VAL A 41 ALA A 54 LYS A 56 LEU A 78 LEU A 170 PHE A 172	ANP A 400 (-4.1A) ANP A 400 (-3.3A) ANP A 400 (-2.9A) None ANP A 400 (-4.0A) None	1.43A	5cswA-1cm8A: 21.1	5cswA-1cm8A: 25.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CSW_B_P06B801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	5 / 12	VAL A 41 ALA A 54 LYS A 56 LEU A 78 PHE A 172	ANP A 400 (-4.1A) ANP A 400 (-3.3A) ANP A 400 (-2.9A) None None	0.79A	5cswB-1cm8A: 20.9	5cswB-1cm8A: 25.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KC4_A_RBFA201_2 (RIBOFLAVIN TRANSPORTER RIBU)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	3 / 3	LYS A 118 LEU A 167 ILE A 215	None	0.58A	5kc4A-1cm8A: 0.3	5kc4A-1cm8A: 21.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5LW1_B_ADNB401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	6 / 9	VAL A 41 ALA A 54 ILE A 87 MET A 109 MET A 112 LEU A 170	ANP A 400 (-4.1A) ANP A 400 (-3.3A) ANP A 400 (-4.9A) ANP A 400 (-4.6A) None ANP A 400 (-4.0A)	0.69A	5lw1B-1cm8A: 35.8	5lw1B-1cm8A: 42.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5LW1_E_ADNE401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	6 / 10	VAL A 41 ALA A 54 ILE A 87 MET A 109 MET A 112 LEU A 170	ANP A 400 (-4.1A) ANP A 400 (-3.3A) ANP A 400 (-4.9A) ANP A 400 (-4.6A) None ANP A 400 (-4.0A)	0.66A	5lw1E-1cm8A: 26.2	5lw1E-1cm8A: 42.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5LW1_H_ADNH401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	5 / 9	VAL A 41 ALA A 54 MET A 109 MET A 112 LEU A 170	ANP A 400 (-4.1A) ANP A 400 (-3.3A) ANP A 400 (-4.6A) None ANP A 400 (-4.0A)	0.62A	5lw1H-1cm8A: 35.8	5lw1H-1cm8A: 42.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MO4_A_NILA601_1 (TYROSINE-PROTEIN KINASE ABL1)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	5 / 10	VAL A 41 LYS A 56 GLU A 74 PHE A 111 MET A 112	ANP A 400 (-4.1A) ANP A 400 (-2.9A) None ANP A 400 ( 4.3A) None	0.69A	5mo4A-1cm8A: 18.7	5mo4A-1cm8A: 22.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OS7_B_ACTB401_0 (CASEIN KINASE II SUBUNIT ALPHA)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	4 / 5	ARG A 73 ARG A 152 LEU A 174 VAL A 186	TPO A 183 ( 2.8A) TPO A 183 ( 2.8A) None PTR A 185 ( 2.8A)	1.00A	5os7B-1cm8A: 29.8	5os7B-1cm8A: 28.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5OSR_A_ACTA401_0 (CASEIN KINASE II SUBUNIT ALPHA)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	4 / 5	LYS A 69 ARG A 73 ARG A 152 LEU A 174	TPO A 183 ( 2.8A) TPO A 183 ( 2.8A) TPO A 183 ( 2.8A) None	0.81A	5osrA-1cm8A: 28.8	5osrA-1cm8A: 30.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5OTR_A_ACTA401_0 (CASEIN KINASE II SUBUNIT ALPHA)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	4 / 5	LYS A 69 ARG A 73 ARG A 152 LEU A 174	TPO A 183 ( 2.8A) TPO A 183 ( 2.8A) TPO A 183 ( 2.8A) None	0.97A	5otrA-1cm8A: 28.5	5otrA-1cm8A: 30.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XXI_A_LSNA503_1 (CYTOCHROME P450 2C9)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	5 / 12	LEU A 225 PHE A 273 PRO A 245 THR A 244 LEU A 268	None	1.20A	5xxiA-1cm8A: 0.0	5xxiA-1cm8A: 21.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YW0_A_ACTA411_0 (UNCHARACTERIZED PROTEIN KDOO)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	3 / 3	LYS A 186 LEU A 174 ARG A 152	PTR A 185 ( 3.6A) None TPO A 183 ( 2.8A)	0.72A	5yw0A-1cm8A: 0.0	5yw0A-1cm8A: 23.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YWM_X_NIOX403_0 (CASEIN KINASE II SUBUNIT ALPHA')	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	4 / 7	VAL A 41 LYS A 56 ILE A 87 ASP A 171	ANP A 400 (-4.1A) ANP A 400 (-2.9A) ANP A 400 (-4.9A) MG A 402 (-2.3A)	0.42A	5ywmX-1cm8A: 30.2	5ywmX-1cm8A: 12.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6GMD_A_ACTA401_0 (CASEIN KINASE II SUBUNIT ALPHA)	1cm8	PHOSPHORYLATED MAP KINASE P38-GAMMA (Homo sapiens)	4 / 5	ARG A 73 ARG A 152 LEU A 174 VAL A 186	TPO A 183 ( 2.8A) TPO A 183 ( 2.8A) None PTR A 185 ( 2.8A)	1.00A	6gmdA-1cm8A: 29.8	6gmdA-1cm8A: 28.10

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1DRE_A_MTXA161_1","DIHYDROFOLATE REDUCTASE","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",5,"ALA A 305;MET A 291;LEU A 141;ILE A 215;LEU A 159","None","1.12A","1dreA-1cm8A:undetectable","1dreA-1cm8A:18.61"],["1GTI_A_CCSA47_0","GLUTATHIONE S-TRANSFERASE","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",4,"THR A 114;LEU A 116;GLY A 157;LEU A 170","None;None;ANP A 400 (-4.3A);ANP A 400 (-4.0A)","0.93A","1gtiA-1cm8A:undetectable","1gtiA-1cm8A:22.53"],["1GTI_E_CCSE47_0","GLUTATHIONE S-TRANSFERASE","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",4,"THR A 114;LEU A 116;GLY A 157;LEU A 170","None;None;ANP A 400 (-4.3A);ANP A 400 (-4.0A)","1.00A","1gtiE-1cm8A:0.0","1gtiE-1cm8A:22.53"],["1RX3_A_MTXA161_1","DIHYDROFOLATE REDUCTASE","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",5,"ALA A 305;MET A 291;LEU A 141;ILE A 215;LEU A 159","None","1.12A","1rx3A-1cm8A:undetectable","1rx3A-1cm8A:18.61"],["1XKK_A_FMMA91_2","EPIDERMAL GROWTH FACTOR RECEPTOR","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",5,"VAL A  41;LYS A  56;LEU A  89;LEU A 107;MET A 112","ANP A 400 (-4.1A);ANP A 400 (-2.9A);None;None;None","0.68A","1xkkA-1cm8A:21.2","1xkkA-1cm8A:27.20"],["2PGZ_D_COCD401_1","SOLUBLE ACETYLCHOLINE RECEPTOR;SOLUBLE ACETYLCHOLINE RECEPTOR","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",4,"TYR A 106;TRP A  21;TYR A  12;GLN A  31","None","1.36A","2pgzD-1cm8A:0.0;2pgzE-1cm8A:undetectable","2pgzD-1cm8A:21.04;2pgzE-1cm8A:21.04"],["2QEI_A_CXXA802_1","TRANSPORTER","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",4,"SER A 229;ARG A 189;ARG A 192;ILE A 197","None;PTR A 185 ( 3.6A);PTR A 185 ( 3.1A);None","1.15A","2qeiA-1cm8A:0.0","2qeiA-1cm8A:21.89"],["2TSR_B_D16B409_1","THYMIDYLATE SYNTHASE","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",4,"ARG A 176;ILE A 149;LEU A 141;GLY A 140","TPO A 183 ( 3.9A);None;None;None","0.78A","2tsrB-1cm8A:undetectable","2tsrB-1cm8A:22.34"],["3GCS_A_BAXA401_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",5,"ALA A  54;LEU A  78;ILE A  87;ILE A 144;HIS A 151","ANP A 400 (-3.3A);None;ANP A 400 (-4.9A);None;None","0.98A","3gcsA-1cm8A:24.5","3gcsA-1cm8A:60.22"],["3GCS_A_BAXA401_2","MITOGEN-ACTIVATED PROTEIN KINASE 14","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",4,"MET A  81;VAL A  86;ILE A 149;ILE A 169","None","0.74A","3gcsA-1cm8A:23.5","3gcsA-1cm8A:60.22"],["3GP0_A_NILA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 11","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",7,"ALA A  54;LEU A  78;ILE A  87;HIS A 151;ALA A 160;LEU A 170;ASP A 171","ANP A 400 (-3.3A);None;ANP A 400 (-4.9A);None;ANP A 400 ( 4.7A);ANP A 400 (-4.0A); MG A 402 (-2.3A)","1.04A","3gp0A-1cm8A:37.8","3gp0A-1cm8A:63.07"],["3GP0_A_NILA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 11","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",9,"VAL A  41;ALA A  54;GLU A  74;LEU A  77;LEU A  78;ILE A  87;HIS A 151;ALA A 160;LEU A 170","ANP A 400 (-4.1A);ANP A 400 (-3.3A);None;None;None;ANP A 400 (-4.9A);None;ANP A 400 ( 4.7A);ANP A 400 (-4.0A)","0.76A","3gp0A-1cm8A:37.8","3gp0A-1cm8A:63.07"],["3GP0_A_NILA1_2","MITOGEN-ACTIVATED PROTEIN KINASE 11","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",5,"ARG A  70;VAL A  86;LEU A 107;MET A 112;ILE A 169","None","0.75A","3gp0A-1cm8A:37.8","3gp0A-1cm8A:63.07"],["3HEC_A_STIA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",5,"ALA A  54;GLU A  74;LEU A  78;ILE A  87;LEU A 170","ANP A 400 (-3.3A);None;None;ANP A 400 (-4.9A);ANP A 400 (-4.0A)","0.77A","3hecA-1cm8A:36.7","3hecA-1cm8A:61.84"],["3HEC_A_STIA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",6,"VAL A  33;ALA A  54;LYS A  56;GLU A  74;LEU A  78;ILE A  87","ANP A 400 ( 4.9A);ANP A 400 (-3.3A);ANP A 400 (-2.9A);None;None;ANP A 400 (-4.9A)","0.68A","3hecA-1cm8A:36.7","3hecA-1cm8A:61.84"],["3HEC_A_STIA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",5,"VAL A  33;ALA A  54;LYS A  56;LEU A  77;LEU A  78","ANP A 400 ( 4.9A);ANP A 400 (-3.3A);ANP A 400 (-2.9A);None;None","0.73A","3hecA-1cm8A:36.7","3hecA-1cm8A:61.84"],["3HEG_A_BAXA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",6,"VAL A  33;VAL A  41;ALA A  54;LYS A  56;GLU A  74;ILE A 144","ANP A 400 ( 4.9A);ANP A 400 (-4.1A);ANP A 400 (-3.3A);ANP A 400 (-2.9A);None;None","1.09A","3hegA-1cm8A:36.9","3hegA-1cm8A:61.84"],["3HEG_A_BAXA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",7,"VAL A  33;VAL A  41;ALA A  54;LYS A  56;LEU A  78;ILE A  87;ILE A 144","ANP A 400 ( 4.9A);ANP A 400 (-4.1A);ANP A 400 (-3.3A);ANP A 400 (-2.9A);None;ANP A 400 (-4.9A);None","1.14A","3hegA-1cm8A:36.9","3hegA-1cm8A:61.84"],["3HEG_A_BAXA1_2","MITOGEN-ACTIVATED PROTEIN KINASE 14","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",5,"MET A  81;VAL A  86;ILE A 149;HIS A 151;ILE A 169","None","0.60A","3hegA-1cm8A:36.9","3hegA-1cm8A:61.84"],["3HEG_A_BAXA1_2","MITOGEN-ACTIVATED PROTEIN KINASE 14","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",5,"VAL A  86;ILE A 149;HIS A 151;ILE A 169;LEU A 170","None;None;None;None;ANP A 400 (-4.0A)","0.77A","3hegA-1cm8A:36.9","3hegA-1cm8A:61.84"],["3LFA_A_1N1A361_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",6,"VAL A  33;ALA A  54;LYS A  56;GLU A  74;LEU A 107;MET A 112","ANP A 400 ( 4.9A);ANP A 400 (-3.3A);ANP A 400 (-2.9A);None;None;None","0.50A","3lfaA-1cm8A:35.6","3lfaA-1cm8A:61.04"],["3N23_A_OBNA1_1","SODIUM\/POTASSIUM-TRANSPORTING ATPASE SUBUNIT ALPHA-1","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",5,"PRO A 353;ASP A  91;VAL A  53;ALA A  44;ILE A  55","None","1.39A","3n23A-1cm8A:0.0","3n23A-1cm8A:16.33"],["3OHT_A_1N1A1000_1","P38A","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",6,"VAL A  33;VAL A  41;ALA A  54;LEU A  78;ILE A  87;LEU A 170","ANP A 400 ( 4.9A);ANP A 400 (-4.1A);ANP A 400 (-3.3A);None;ANP A 400 (-4.9A);ANP A 400 (-4.0A)","0.57A","3ohtA-1cm8A:8.3","3ohtA-1cm8A:58.02"],["3OHT_A_1N1A1000_1","P38A","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",6,"VAL A  33;VAL A  41;ALA A  54;LYS A  56;LEU A  78;ILE A  87","ANP A 400 ( 4.9A);ANP A 400 (-4.1A);ANP A 400 (-3.3A);ANP A 400 (-2.9A);None;ANP A 400 (-4.9A)","0.60A","3ohtA-1cm8A:8.3","3ohtA-1cm8A:58.02"],["3OHT_B_1N1B1000_1","P38A","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",6,"VAL A  41;ALA A  54;LEU A  78;ILE A  87;GLY A 113;LEU A 170","ANP A 400 (-4.1A);ANP A 400 (-3.3A);None;ANP A 400 (-4.9A);None;ANP A 400 (-4.0A)","0.80A","3ohtB-1cm8A:6.2","3ohtB-1cm8A:58.02"],["3OHT_B_1N1B1000_1","P38A","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",6,"VAL A  41;ALA A  54;LYS A  56;LEU A  78;ILE A  87;GLY A 113","ANP A 400 (-4.1A);ANP A 400 (-3.3A);ANP A 400 (-2.9A);None;ANP A 400 (-4.9A);None","0.66A","3ohtB-1cm8A:6.2","3ohtB-1cm8A:58.02"],["3QL0_A_FOLA160_0","DIHYDROFOLATE REDUCTASE","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",5,"ALA A 305;MET A 291;LEU A 141;ILE A 215;LEU A 159","None","1.20A","3ql0A-1cm8A:undetectable","3ql0A-1cm8A:17.78"],["3SEL_X_DXCX75_0","CYTOCHROME C7","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",4,"ILE A 169;LEU A 159;MET A 216;GLY A 213","None","0.87A","3selX-1cm8A:undetectable","3selX-1cm8A:12.19"],["3UCJ_A_AZMA229_2","CARBONIC ANHYDRASE;CARBONIC ANHYDRASE","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",3,"GLN A  63;PHE A  67;TYR A  59","None","0.95A","3ucjB-1cm8A:undetectable","3ucjB-1cm8A:19.02"],["3UCJ_B_AZMB229_1","CARBONIC ANHYDRASE;CARBONIC ANHYDRASE","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",3,"GLN A  63;PHE A  67;TYR A  59","None","0.96A","3ucjA-1cm8A:undetectable","3ucjA-1cm8A:19.02"],["3WAR_A_NIOA401_1","CASEIN KINASE II SUBUNIT ALPHA","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",4,"VAL A  41;LYS A  56;ILE A  87;ASP A 171","ANP A 400 (-4.1A);ANP A 400 (-2.9A);ANP A 400 (-4.9A); MG A 402 (-2.3A)","0.59A","3warA-1cm8A:29.8","3warA-1cm8A:30.15"],["3WZE_A_BAXA1201_1","VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",7,"VAL A  41;ALA A  54;LYS A  56;GLU A  74;LEU A  78;PHE A 111;HIS A 151","ANP A 400 (-4.1A);ANP A 400 (-3.3A);ANP A 400 (-2.9A);None;None;ANP A 400 ( 4.3A);None","0.58A","3wzeA-1cm8A:20.8","3wzeA-1cm8A:25.19"],["4ASD_A_BAXA1500_1","VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",7,"VAL A  41;ALA A  54;LYS A  56;GLU A  74;LEU A  78;PHE A 111;HIS A 151","ANP A 400 (-4.1A);ANP A 400 (-3.3A);ANP A 400 (-2.9A);None;None;ANP A 400 ( 4.3A);None","0.59A","4asdA-1cm8A:20.6","4asdA-1cm8A:24.88"],["4GH8_A_MTXA201_1","DIHYDROFOLATE REDUCTASE","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",5,"ALA A 305;MET A 291;LEU A 141;ILE A 215;LEU A 159","None","1.13A","4gh8A-1cm8A:undetectable","4gh8A-1cm8A:17.17"],["4HAJ_A_DXCA75_0","PPCA","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",4,"ILE A 169;LEU A 159;MET A 216;GLY A 213","None","0.94A","4hajA-1cm8A:undetectable","4hajA-1cm8A:17.98"],["4I41_A_MIXA500_1","SERINE\/THREONINE-PROTEIN KINASE PIM-1","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",8,"VAL A  41;ALA A  54;ILE A  87;ASP A 115;ASP A 153;LYS A 155;ASN A 158;ASP A 171","ANP A 400 (-4.1A);ANP A 400 (-3.3A);ANP A 400 (-4.9A);ANP A 400 (-3.4A);ANP A 400 ( 4.7A);ANP A 400 (-3.5A); MG A 401 ( 2.9A); MG A 402 (-2.3A)","0.94A","4i41A-1cm8A:24.7","4i41A-1cm8A:27.35"],["4IIZ_B_LURB201_1","TRANSTHYRETIN","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",4,"GLU A 297;THR A 206;LEU A 294;VAL A 207","None","0.94A","4iizB-1cm8A:0.5","4iizB-1cm8A:15.30"],["4L9I_A_8PRA601_1","RHODOPSIN KINASE","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",4,"VAL A  41;ALA A  54;LEU A  58;MET A 109","ANP A 400 (-4.1A);ANP A 400 (-3.3A);None;ANP A 400 (-4.6A)","0.62A","4l9iA-1cm8A:10.4","4l9iA-1cm8A:22.78"],["4OGR_A_ADNA401_1","CYCLIN-DEPENDENT KINASE 9","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",5,"VAL A  41;ALA A  54;ASP A 115;ASN A 158;ASP A 171","ANP A 400 (-4.1A);ANP A 400 (-3.3A);ANP A 400 (-3.4A); MG A 401 ( 2.9A); MG A 402 (-2.3A)","0.61A","4ogrA-1cm8A:25.9","4ogrA-1cm8A:32.56"],["4UXQ_A_0LIA1752_2","FIBROBLAST GROWTH FACTOR RECEPTOR 4","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",4,"VAL A  41;ILE A  87;ARG A 152;ILE A 169","ANP A 400 (-4.1A);ANP A 400 (-4.9A);TPO A 183 ( 2.8A);None","0.75A","4uxqA-1cm8A:19.2","4uxqA-1cm8A:24.68"],["4XV2_A_P06A801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",5,"VAL A  41;ALA A  54;LYS A  56;ASP A 171;PHE A 172","ANP A 400 (-4.1A);ANP A 400 (-3.3A);ANP A 400 (-2.9A); MG A 402 (-2.3A);None","0.70A","4xv2A-1cm8A:21.4","4xv2A-1cm8A:25.20"],["4XV2_B_P06B801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",5,"ALA A  54;LYS A  56;LEU A  78;ASP A 171;PHE A 172","ANP A 400 (-3.3A);ANP A 400 (-2.9A);None; MG A 402 (-2.3A);None","0.85A","4xv2B-1cm8A:21.6","4xv2B-1cm8A:25.20"],["5CSH_B_ACTB401_0","CASEIN KINASE II SUBUNIT ALPHA","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",4,"ARG A  73;ARG A 152;LEU A 174;VAL A 186","TPO A 183 ( 2.8A);TPO A 183 ( 2.8A);None;PTR A 185 ( 2.8A)","0.95A","5cshB-1cm8A:29.4","5cshB-1cm8A:28.10"],["5CSW_A_P06A801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",6,"VAL A  41;ALA A  54;LYS A  56;LEU A  78;LEU A 170;PHE A 172","ANP A 400 (-4.1A);ANP A 400 (-3.3A);ANP A 400 (-2.9A);None;ANP A 400 (-4.0A);None","1.43A","5cswA-1cm8A:21.1","5cswA-1cm8A:25.27"],["5CSW_B_P06B801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",5,"VAL A  41;ALA A  54;LYS A  56;LEU A  78;PHE A 172","ANP A 400 (-4.1A);ANP A 400 (-3.3A);ANP A 400 (-2.9A);None;None","0.79A","5cswB-1cm8A:20.9","5cswB-1cm8A:25.27"],["5KC4_A_RBFA201_2","RIBOFLAVIN TRANSPORTER RIBU","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",3,"LYS A 118;LEU A 167;ILE A 215","None","0.58A","5kc4A-1cm8A:0.3","5kc4A-1cm8A:21.08"],["5LW1_B_ADNB401_1","MITOGEN-ACTIVATED PROTEIN KINASE 8","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",6,"VAL A  41;ALA A  54;ILE A  87;MET A 109;MET A 112;LEU A 170","ANP A 400 (-4.1A);ANP A 400 (-3.3A);ANP A 400 (-4.9A);ANP A 400 (-4.6A);None;ANP A 400 (-4.0A)","0.69A","5lw1B-1cm8A:35.8","5lw1B-1cm8A:42.50"],["5LW1_E_ADNE401_1","MITOGEN-ACTIVATED PROTEIN KINASE 8","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",6,"VAL A  41;ALA A  54;ILE A  87;MET A 109;MET A 112;LEU A 170","ANP A 400 (-4.1A);ANP A 400 (-3.3A);ANP A 400 (-4.9A);ANP A 400 (-4.6A);None;ANP A 400 (-4.0A)","0.66A","5lw1E-1cm8A:26.2","5lw1E-1cm8A:42.50"],["5LW1_H_ADNH401_1","MITOGEN-ACTIVATED PROTEIN KINASE 8","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",5,"VAL A  41;ALA A  54;MET A 109;MET A 112;LEU A 170","ANP A 400 (-4.1A);ANP A 400 (-3.3A);ANP A 400 (-4.6A);None;ANP A 400 (-4.0A)","0.62A","5lw1H-1cm8A:35.8","5lw1H-1cm8A:42.50"],["5MO4_A_NILA601_1","TYROSINE-PROTEIN KINASE ABL1","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",5,"VAL A  41;LYS A  56;GLU A  74;PHE A 111;MET A 112","ANP A 400 (-4.1A);ANP A 400 (-2.9A);None;ANP A 400 ( 4.3A);None","0.69A","5mo4A-1cm8A:18.7","5mo4A-1cm8A:22.68"],["5OS7_B_ACTB401_0","CASEIN KINASE II SUBUNIT ALPHA","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",4,"ARG A  73;ARG A 152;LEU A 174;VAL A 186","TPO A 183 ( 2.8A);TPO A 183 ( 2.8A);None;PTR A 185 ( 2.8A)","1.00A","5os7B-1cm8A:29.8","5os7B-1cm8A:28.10"],["5OSR_A_ACTA401_0","CASEIN KINASE II SUBUNIT ALPHA","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",4,"LYS A  69;ARG A  73;ARG A 152;LEU A 174","TPO A 183 ( 2.8A);TPO A 183 ( 2.8A);TPO A 183 ( 2.8A);None","0.81A","5osrA-1cm8A:28.8","5osrA-1cm8A:30.65"],["5OTR_A_ACTA401_0","CASEIN KINASE II SUBUNIT ALPHA","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",4,"LYS A  69;ARG A  73;ARG A 152;LEU A 174","TPO A 183 ( 2.8A);TPO A 183 ( 2.8A);TPO A 183 ( 2.8A);None","0.97A","5otrA-1cm8A:28.5","5otrA-1cm8A:30.65"],["5XXI_A_LSNA503_1","CYTOCHROME P450 2C9","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",5,"LEU A 225;PHE A 273;PRO A 245;THR A 244;LEU A 268","None","1.20A","5xxiA-1cm8A:0.0","5xxiA-1cm8A:21.62"],["5YW0_A_ACTA411_0","UNCHARACTERIZED PROTEIN KDOO","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",3,"LYS A 186;LEU A 174;ARG A 152","PTR A 185 ( 3.6A);None;TPO A 183 ( 2.8A)","0.72A","5yw0A-1cm8A:0.0","5yw0A-1cm8A:23.65"],["5YWM_X_NIOX403_0","CASEIN KINASE II SUBUNIT ALPHA'","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",4,"VAL A  41;LYS A  56;ILE A  87;ASP A 171","ANP A 400 (-4.1A);ANP A 400 (-2.9A);ANP A 400 (-4.9A); MG A 402 (-2.3A)","0.42A","5ywmX-1cm8A:30.2","5ywmX-1cm8A:12.84"],["6GMD_A_ACTA401_0","CASEIN KINASE II SUBUNIT ALPHA","1cm8","PHOSPHORYLATED MAP KINASE P38-GAMMA","Homo sapiens",4,"ARG A  73;ARG A 152;LEU A 174;VAL A 186","TPO A 183 ( 2.8A);TPO A 183 ( 2.8A);None;PTR A 185 ( 2.8A)","1.00A","6gmdA-1cm8A:29.8","6gmdA-1cm8A:28.10"]]